Acute retinal necrosis and ocular neovascularization caused by cytomegalovirus following intravitreal dexamethasone implant (Ozurdex®) in an immunocompetent patient.
Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway.
Alexander S
AS
Thrane
Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway.
Morten
M
Hove
Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway.
Bård
B
Kjersem
Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway.|Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Jørgen
J
Krohn
D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology*; D003907:Dexamethasone / Q000008:administration & dosage*; D004343:Drug Implants; D004359:Drug Therapy, Combination; D015828:Eye Infections, Viral / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology*; D005451:Fluorescein Angiography; D015774:Ganciclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D058449:Intravitreal Injections; D007498:Iris / Q000098:blood supply*; D017075:Laser Coagulation; D008297:Male; D009389:Neovascularization, Pathologic / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology*; D015864:Panuveitis / Q000188:drug therapy; D016133:Polymerase Chain Reaction; D015882:Retinal Necrosis Syndrome, Acute / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology*; D000077562:Valganciclovir
D000998:Antiviral Agents; D004343:Drug Implants; D005938:Glucocorticoids; D003907:Dexamethasone; D000077562:Valganciclovir; D015774:Ganciclovir